Columbia Research Enhanced Value ETF
REVS
1 hedge funds and large institutions have $191K invested in Columbia Research Enhanced Value ETF in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
38% less capital invested
Capital invested by funds: $307K → $191K (-$116K)
55.19% less ownership
Funds ownership: 60.76% → 5.57% (-55%)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$307K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HI
1
Harbour Investments
Madison,
Wisconsin
| $191K | +$180K | +10,025 | New |
|
|
2
Jane Street
New York
| – | -$307K | -18,228 | Closed |
|
REVS Hedge Fund Activity: Q1 2021 in Review
1 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q1 2021, worth a combined $191K — down 38% from $307K a quarter earlier.
Fund positioning in REVS was balanced in Q1 2021: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Jane Street, exiting entirely with an estimated $307K sold.
- 1 institutional investor held Columbia Research Enhanced Value ETF (REVS) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $191K of Columbia Research Enhanced Value ETF stock for Q1 2021, down 38% quarter-over-quarter.
- 1 fund opened new Columbia Research Enhanced Value ETF positions in Q1 2021 and 1 closed out, a net change of 0 holders.
- The largest Columbia Research Enhanced Value ETF seller in Q1 2021 was Jane Street, an estimated $307K sold.
Based on aggregated 13F filings for Q1 2021.